Table 4.
Outcomes of implemented actions reported by general practitioner (GP) at follow-up
| Outcome of action | Frequency | Percent |
|---|---|---|
| Positive | 212 | 70.9 |
| Action taken leading to improvement in symptoms, function or disease | 66 | 22.1 |
| Action taken on drug use with no recorded negative or positive clinical outcomes | 51 | 17.1 |
| Action taken but reports of no change in symptoms, function, disease or drug use | 2 | 0.7 |
| Information provided to the patient to prevent possible dangers | 93 | 31.1 |
| Neutral | 47 | 15.7 |
| Outcome not mentioned | 4 | 1.3 |
| Action unclear | 5 | 1.7 |
| Monitoring – initiated – no results/effects reported or specified | 25 | 8.4 |
| Monitoring – results show normal or within therapeutic range | 13 | 4.3 |
| Negative | 11 | 3.7 |
| Development of side-effects/worsening in symptoms, function or disease; previous treatment re-started | 8 | 2.7 |
| Drug change trialled but re-started without an explanation | 3 | 1.0 |
| Actions planned but outcome unknown | 29 | 9.7 |
| Total | 299 | 100.0 |
Feedback for 71 patients, no records for 30 patients = 183 recommendations; 265 recommendations did not apply because they were not enacted, such as local pharmacy to take action (e.g. introduce Dose Administration Aids), referral to specialist, no recommendation made or information given to pharmacist by GP (Table 3).